MARC Record from marc_columbia

LEADER: 07169pam a22004454a 4500
001 5620898
005 20221121194621.0
008 051001s2006 nyua b 001 0 eng
010 $a 2005054882
016 7 $a101258792$2DNLM
020 $a0824754255 (alk. paper)
024 3 $a9780824754259
029 1 $aNLM$b101258792
035 $a(OCoLC)ocm62078261
035 $a(NNC)5620898
035 $a5620898
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dBAKER$dOrLoB-B
042 $apcc
050 00 $aQR201.E75$bE64 2006
060 10 $aW1$bIN406HMN v.38 2006
060 10 $aWC 571$bE64 2006
082 00 $a616.9/101$222
245 00 $aEpstein-Barr virus /$cedited by Alex Tselis, Hal B. Jenson.
260 $aNew York :$bTaylor & Francis,$c2006.
300 $axviii, 406 pages :$billustrations (some color) ;$c27 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInfectious disease and therapy ;$v38
504 $aIncludes bibliographical references and index.
505 00 $tForeword /$rGeorge Miller -- $g1.$tThe History of Epstein-Barr Virus /$rAlex Tselis -- $g2.$tVirology and Molecular Biology of Epstein-Barr Virus /$rJeffrey I. Cohen -- $tVirus Structure and Genome -- $tVirus Replication -- $tLatent Infection -- $tLytic Infection -- $g3.$tEpidemiology of Primary Epstein-Barr Virus Infection and Infectious Mononucleosis /$rWarren A. Andiman -- $tSources of Epidemiologic Data -- $tDescriptive Epidemiology -- $g4.$tPathology of Primary and Persistent Epstein-Barr Virus Infection /$rGerald Niedobitek and Hermann Herbst -- $tInfectious Mononucleosis -- $tPersistent EBV Infection -- $tEBV Replication in Primary and Persistent Infection -- $tFatal IM, CAEBV Infection, and EBV-AHS -- $tExpression of Cytokine and Chemokine Genes in IM and CAEBV Infection -- $g5.$tThe Immune Response to Epstein-Barr Virus /$rScott R. Burrows and Andrew D. Hislop -- $tHumoral Response -- $tT-Cell Response During IM and After Resolution of Disease -- $tT-Cell Response in Asymptomatic Primary Infection -- $tT-Cell Response in Healthy Virus Carriers -- $tT-Cell-Mediated Control of EBV-Associated Tumors -- $tTCR Selection -- $tConcluding Remarks and Future Directions -- $g6.$tClinical Features of Infectious Mononucleosis /$rJan Andersson -- $tClinical Characterization of Acute Infectious Mononucleosis -- $tAtypical Presentations of Acute IM -- $tAcute Complications of EBV IM -- $tTherapy of Acute Infection -- $g7.$tEpstein-Barr Virus Disease-Serologic and Virologic Diagnosis /$rAlex Tselis, Joseph R. Merline and Gregory A. Storch -- $tHeterophile Antibodies -- $tConventional EBV Serologic Tests -- $tDetermining EBV Status Based on Serological Panels -- $tDetection of EBV by Viral Culture -- $tDetection of EBV Genome -- $tDirect Detection of Latent EBV Infection -- $tUse of EBV Diagnostic Tests in Selected Clinical Circumstances -- $g8.$tEpstein-Barr Virus and the Nervous System /$rAlex Tselis and Kumar Rajamani -- $tEBV-Related Neurological Diseases -- $tTreatment -- $tRelation Between EBV and MS -- $g9.$tEpstein-Barr Virus and HIV /$rRichard F. Ambinder -- $tHIV Infection, EBV Antibody Responses, and EBV Copy Number -- $tViral Strains in HIV-Infected Patients -- $tNon-Neoplastic Manifestations of EBV Infection in HIV-Infected Patients -- $tHIV and Lymphoma -- $tHIV and Other Malignancies -- $tEBV Detection and Clinical Decision Making -- $tPrevention of EBV-Associated Lymphoma -- $tTreatment of EBV-Associated Lymphoma -- $g10.$tBurkitt Lymphoma /$rJeffery T. Sample and Ingrid K. Ruf -- $tClassification and Characteristics of BL -- $tInfectious Cofactors -- $tMolecular Pathogenesis of BL -- $tEBV in BL-Causal Role or B-Cell Cohabitation? -- $tProspects for Future Discovery -- $g11.$tEpstein-Barr Virus Infection in Hodgkin Lymphomas /$rHermann Herbst and Gerald Niedobitek -- $tHistology of HL -- $tBiology of HRS Cells -- $tEBV DNA and RNA in HLs -- $tEBV Antigen Expression in HLs -- $tEBV Infection and the Phenotype of HRS Cells -- $tHL and EBV-Specific Immunity -- $g12.$tPosttransplant Lymphoproliferative Disorder /$rLode J. Swinnen -- $tEpidemiology -- $tPathology of PTLD -- $tClinical Features and Management -- $tEarly Diagnosis and Screening -- $g13.$tT-Cell Lymphomas Associated with Epstein-Barr Virus /$rJames F. Jones -- $tTypes of T-Cell Lymphomas and Their Association with EBV -- $g14.$tNasopharyngeal Carcinoma /$rSai Wah Tsao, Kwok Wai Lo and Dolly P. Huang -- $tEBV Gene Expression During Latent Infection -- $tGenetic Susceptibility of NPC -- $tAssociation of EBV Infection with NPC -- $tGenetic Alterations in NPC -- $tEBV Infection in Epithelial Cells and B Lymphocytes -- $tEBV Infection in Nasopharyngeal Epithelial Cells -- $tTransformation Properties of Gene Products Encoded by EBV -- $tProposed Sequence of Events for NPC Development -- $g15.$tLeiomyosarcoma /$rHal B. Jenson -- $tEpidemiology -- $tPathogenesis -- $g16.$tX-Linked Lymphoproliferative Disease /$rThomas A. Seemayer, Thomas G. Gross, Arpad Lanyi and Janos Sumegi -- $tThe Discovery of the Disease -- $tThe XLP Registry -- $tThe Diagnosis of XLP -- $tClinical Manifestations of XLP -- $tGenotype-Phenotype Correlation -- $tThe Role of EBV Infection in XLP -- $tTreatment and Prognosis -- $tThe XLP Gene -- $tThe XLP Protein -- $tXLP Mutations -- $g17.$tDiseases Possibly Associated with Epstein-Barr Virus /$rJames F. Jones -- $tLaboratory Detection of EBV Infection -- $tMethodological Issues and Their Applications -- $tClinical Illnesses -- $tIdentification of EBV as a Potential Cause of Autoimmune Disease -- $tSynthesis -- $g18.$tTreatment of Epstein-Barr Virus Infections: Chemotherapy, Antiviral Therapy, and Immunotherapy /$rPatrizia Comoli and Cliona Rooney -- $tTreatment of Diseases Associated with EBV Infection -- $tPrevention of EBV Infection or EBV-Associated Disease -- $g19.$tThe Development of Epstein-Barr Virus Vaccines /$rAndrew J. Morgan and A. Douglas Wilson -- $tWhat Is the Demand for EBV Vaccines? -- $tProgress with Other Human Herpesvirus Vaccines -- $tSeveral Alternative Objectives for EBV Vaccination -- $tGP350 Vaccines -- $tGP350 Vaccines and a Primate Model of EBV Lymphoma -- $tPeptide Vaccines -- $tOther Animal Models -- $tHuman Trials -- $tFurther Considerations in EBV Vaccine Design -- $tPossible Therapeutic Vaccination.
650 0 $aEpstein-Barr virus diseases.$0http://id.loc.gov/authorities/subjects/sh87003642
650 0 $aEpstein-Barr virus.$0http://id.loc.gov/authorities/subjects/sh85044491
650 12 $aEpstein-Barr Virus Infections.$0https://id.nlm.nih.gov/mesh/D020031
650 22 $aEpstein-Barr Virus Infections$xvirology.$0https://id.nlm.nih.gov/mesh/D020031Q000821
650 22 $aHerpesvirus 4, Human.$0https://id.nlm.nih.gov/mesh/D004854
650 22 $aLymphoproliferative Disorders.$0https://id.nlm.nih.gov/mesh/D008232
700 1 $aTselis, Alexandros Constantine,$d1956-$0http://id.loc.gov/authorities/names/n86804355
700 1 $aJenson, Hal B.$0http://id.loc.gov/authorities/names/n95801523
830 0 $aInfectious disease and therapy ;$vv. 38.$0http://id.loc.gov/authorities/names/n86726266
852 00 $boff,hsl$hQR201.E75$iE64 2006